PREDICTION OF ADVANCED HEPATIC FIBROSIS, RESPONSE TO PEGYLATED INTERFERON PLUS RIBAVIRIN AND HEPATOCELLULAR CARCINOMA IN EGYPTIAN HCV PATIENTS: A DATA MINING ANALYSISJOURNAL OF HEPATOLOGYIF332014-04-010PREAI
Peginterferon alpha-2a versus peginterferon alpha-2b for chronic hepatitis CCOCHRANE DATABASE OF SYSTEMATIC REVIEWSIF9.42014-02-281OAAI
Peginterferon plus ribavirin versus interferon plus ribavirin for chronic hepatitis CCOCHRANE DATABASE OF SYSTEMATIC REVIEWSIF9.42014-02-2825PREAI
Serum autoantibodies positivity prevalence in patients with chronic HCV and impact on pegylated interferon and ribavirin treatment responseLIVER INTERNATIONALIF5.22013-06-1416PREAI
A NOVEL PREDICTION MODEL FOR LIVER FIBROSIS IN PATIENTS WITH CHRONIC HEPATITIS C VIRUS USING FIBROSCAN AND ROUTINE LABORATORY DATAJOURNAL OF HEPATOLOGYIF332013-04-011PREAI
Health-related quality of life in Egyptian patients after liver transplantationANNALS OF HEPATOLOGYIF4.42012-11-0116OAAI
HEPATIC FIBROSIS AND RESPONSE TO INTERFERON AND RIBAVIRIN THERAPY IN CHRONIC HCV PATIENTS WITH NORMAL LIVER TRANSAMINASESJOURNAL OF HEPATOLOGYIF332012-04-010PREAI
A SUGGESTED ALGORITHM USING BASELINE NON-INVASIVE PARAMETERS FOR THE PREDICTION OF RESPONSE TO TREATMENT IN 3719 HEPATITIS C-INFECTED EGYPTIAN PATIENTSJOURNAL OF HEPATOLOGYIF332012-04-010PREAI
Real-Life Comparison of Pegylated-Interferon 2a Versus 2b Combination Therapy of Chronic Hepatitis C Virus ReplyHEPATOLOGYIF15.82011-04-010OAAI
Proceed With Caution Peginterferon Alpha-2a Versus Peginterferon Alfa-2b in Chronic Hepatitis C. A Systematic Review of Randomized Trials ReplyHEPATOLOGYIF15.82010-11-233PREAI
Peginterferon alpha-2a Is Associated with Higher Sustained Virological Response than Peginterferon alfa-2b in Chronic Hepatitis C: Systematic Review of Randomized TrialsHEPATOLOGYIF15.82010-04-01137PREAI